Canabac retailers from Quebec are struggling to get their supplies.
Last October, shortly after Quebec opened its first chain of medicines, government-run stores were so demanding that they got out of the weeds. Frequently
As an emergency measure, Society Québécoise du Cannabis decided to open its hospital in just four days a week. And according to the SECDC for the Securities Futures, how it will be.
Escudi spokeswoman Fabrice Giguare said, "Supply is still a challenge." "We can open seven days a week only when our supply can justify it. It can not do right now."
Meanwhile, Canada's big producers are increasing production and dramatically increase Quebec-based shipments. Between October and December, Canopy Growth has seen 66-per-cent jump in quantity of cannabis sent to Quebec.
Canopy Growth spokesman Jordan Sinclair said, "It was not a big shock to us that we were selling at the beginning." "We are only manufacturing on a small part of our total footprint because the federal licensing process has become so long. "
Canopy has 5.6 million square feet of production space across the country – making it the largest manufacturer in Canada. So far, only Health Canada is allowed to develop 4.3 million square feet of cannabis.
But there is not a single swamp in half of the space.
Sinclair said, "The licensing was so recent that many of our saplings have not been completed yet."
According to three industry-specific sources, there is a hindrance in the system due to the increase in new applications. Two years ago there were 38 licensed cannabis producers in Canada. Now with 140 more applications left with Canada.
In case of Aurora cannabis – another major supplier – it grew by 30% in Quebec shipments between November and December. Next month, the company's Aurora Sky facility in Edmonton will be fully functional and ready to grow 100,000kg of water every year.
"We appreciate the demand of customers and we continue to increase production," said Heather McGregor, director of communications for Aurora Canabis. "We are committed to making high quality cannabis."
Despite high demand for cannabis, some consumers have turned to uncontrolled drugs on indigenous territories. Last April, months ahead of legalization, Clifford Nicholls opened Smoke Signals Dispensary in Kansette.
At that time, he told the Montreal Gazette that he had the right to sell cannabis on his land as a member of the Sovereign Mohawk nation. Since then, two more clinics broke out in Cancasteck – 45 kilometers west of Montréal.
There are also uncontrolled medicines in the Catwina Zibi region in Khawawk and north of Gatineau.
The shops are well-equipped and equipped with security cameras and magnetic locks. The guard examines the identity of customers and then lets them browse through dried flowers, oils and edibles.
Sources working with experts say that they often get their product from unofficial manufacturers in western Canada – many of them are indigenous – and supply is never a problem.
Production is not monitored by federal regulators, but some Ontario's Aldervell passes through the quality-control process in First Nation, where the buds are inspected for contaminants.
"We have some clients in Quebec who continue to come back because they can not get what they want (SQDC)," said Jordan Brant, who worked in Legacy 420.
In Ontario, one of the dozens on the Tiandenaga Mohawk region, its production has been tested by two bi-chemists who work on the site. Brent says that the legislation does not negatively impact supply or demand for production on Legacy 420.
"People know that (Mohawk) reservation organizations are not legal in Canada's eyes, but they do not care," said Brant. "We have some advantages of pricing, shortage of tax, no waiting time.
"There is a certain atmosphere, we provide some information and skills that I do not think you get (regulation market)."
For licensed manufacturers, Quebec's supply criteria has provided an opportunity for consumers to learn about what they want. Sinclair says, 15 months ago, Canopy made thousands of cannabis pills every week.
Post legalization, their popularity has increased so rapidly that Canopy now has more than 50 million tablets in a year.
Sinclair said, "In more than a year (tablets) do not take into account one-third of our sales of almost one-third of the products." "The part of the challenge is to discover what people want and accept."
Improvement: Jordan Sinclair is wrongly known in the earlier version of this story. They are spokeswoman for Canopy growth.